GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Total Stockholders Equity

Meribank Biotech Co (ROCO:4724) Total Stockholders Equity : NT$609.7 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Total Stockholders Equity?

Meribank Biotech Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$609.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Meribank Biotech Co's Book Value per Share for the quarter that ended in Jun. 2024 was NT$6.93. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Meribank Biotech Co's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.40.

Meribank Biotech Co Total Stockholders Equity Historical Data

The historical data trend for Meribank Biotech Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Total Stockholders Equity Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 434.36 382.64 586.05 471.20 661.73

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 529.73 471.20 406.20 661.73 609.68

Meribank Biotech Co  (ROCO:4724) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Meribank Biotech Co's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(609.679-0)/87.9764
=6.93

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Meribank Biotech Co's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(28.837 + 214.129) / 609.679
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Total Stockholders Equity
Comparable Companies
ROCO:6564 ROCO:6580 TPE:1733 ROCO:7427 ROCO:4194 ROCO:6879 ROCO:4130 ROCO:6846 TPE:3164 ROCO:4168 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Website
http://www.meribank.com.tw
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co Headlines

No Headlines